Abbott Wins IP Validity Ruling In Niaspan Suit
The Delaware judge overseeing Abbott Laboratories' lawsuit over Lupin Ltd.'s efforts to make a generic version of the blockbuster cholesterol drug Niaspan handed Abbott a judgment on Thursday of no invalidity...To view the full article, register now.
Already a subscriber? Click here to view full article